In the first study of its kind, researchers from the Keck School of Medicine of USC found an association between levels of manmade “forever chemicals” in drinking water and the incidence of certain digestive, endocrine, respiratory, and mouth and throat cancers.
Communities exposed to drinking water contaminated with manufactured chemicals known as per- and polyfluoroalkyl substances (PFAS) experience up to a 33% higher incidence of certain cancers, according to new research from the Keck School of Medicine of USC.
The study, funded by the National Institutes of Health and just published in the Journal of Exposure Science and Environmental Epidemiology, is the first to examine cancer and PFAS contamination of drinking water in the U.S.
PFAS, which are used in consumer products such as furniture and food packaging, have been found in about 45% of drinking water supplies across the United States. Past research has linked the chemicals, which are slow to break down and accumulate in the body over time, to a range of health problems, including kidney, breast and testicular cancers…
Source: Keck School of Medicine of USC (University of Southern California)
Author: Zara Abrams
Lastes news from Keck School of Medicine of USC
- USC launches clinical trial of psilocybin and mindfulness meditation for depression
- USC Street Medicine symposium offers hope and solutions for homeless patients
- THE LOS ANGELES TIMES ◆ ER visits from foreign-born patients fell drastically during ICE raids, study finds
- USC Trustee Alia Tutor establishes endowed chair to advance clinical excellence at USC
- N+ UNIVISION 34 LOS ÁNGELES ◆ National Latino Physician Day with Keck School of Medicine of USC 4th Year Med Student Kelvin Álvarez
- American Academy of Ophthalmology (AAO) 2026 schedule for the USC Roski Eye Institute
- $8 million NIH grant advances research on environmental health
- USC professor and division chief Mohammad Soleimani uses his ingenuity to help patients recover their sight
- Investing in Innovation
- PKD Foundation provides support for kidney disease research by USC Stem Cell’s Zhongwei Li
